Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Taniguchi

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 17, 2013
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumoniaYuichiro Shindo, Ryota Ito, Daisuke Kobayashi, et al.
ERJ Open Research|June 5, 2020
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in JapanYuji Minegishi, Akihiko Gemma, Sakae Homma, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 4, 2021
Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory DiseasesNobuhiro Tanabe, Hiraku Kumamaru, Yuichi Tamura, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
Respiratory Investigation|December 26, 2016
The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition)Tsuneto Akashiba, Yuka Ishikawa, Hideki Ishihara, et al.
Respiratory Investigation|July 8, 2018
Japanese guideline for the treatment of idiopathic pulmonary fibrosisSakae Homma, Masashi Bando, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2020
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled TrialYasuhiro Kondoh, Arata Azuma, Yoshikazu Inoue, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2019
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L F Walsh, David J Lederer, Christopher J Ryerson, et al.
The Lancet. Respiratory Medicine|May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort studySimon L F Walsh, Athol U Wells, Sujal R Desai, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
American Journal of Respiratory and Critical Care Medicine|July 17, 2013
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumoniaYuichiro Shindo, Ryota Ito, Daisuke Kobayashi, et al.
ERJ Open Research|June 5, 2020
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in JapanYuji Minegishi, Akihiko Gemma, Sakae Homma, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 4, 2021
Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory DiseasesNobuhiro Tanabe, Hiraku Kumamaru, Yuichi Tamura, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
Respiratory Investigation|December 26, 2016
The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition)Tsuneto Akashiba, Yuka Ishikawa, Hideki Ishihara, et al.
Respiratory Investigation|July 8, 2018
Japanese guideline for the treatment of idiopathic pulmonary fibrosisSakae Homma, Masashi Bando, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2020
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled TrialYasuhiro Kondoh, Arata Azuma, Yoshikazu Inoue, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2019
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L F Walsh, David J Lederer, Christopher J Ryerson, et al.
The Lancet. Respiratory Medicine|May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort studySimon L F Walsh, Athol U Wells, Sujal R Desai, et al.
Pageof 18